IL6 and hepatocellular carcinoma: As shown in the Fig. 3B and Supplementary Fig. 7, we found that in response to treatment with NVP-BEZ235, expression of IL-6 in HCC cells was significantly upregulated, which may lead to an inflammatory reaction in the body.